Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives

Por Ong, Pei Shi, Wang, Louis Z., Dai, Xiaoyun, Tseng, Sheng Hsuan, Loo, Shang Jun, Sethi, Gautam
Publicado no Front Pharmacol (2016)

Quantification of trans-2,6-difluoro-4′-N,N-dimethylaminostilbene in rat plasma: Application to a pharmacokinetic study

Por Lin, Hai-Shu, Sviripa, Vitaliy M., Watt, David S., Liu, Chunming, Xiang, Tian-Xiang, Anderson, Bradley D., Ong, Pei Shi, Ho, Paul C.
Publicado em 2012

Association of Eleven Common, Low-Penetrance Colorectal Cancer Susceptibility Genetic Variants at Six Risk Loci with Clinical Outcome

Por Hoskins, Janelle M., Ong, Pei-Shi, Keku, Temitope O., Galanko, Joseph A., Martin, Christopher F., Coleman, Clint A., Wolfe, Michelle, Sandler, Robert S., McLeod, Howard L.
Publicado em 2012

Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development

Por Wang, Lingzhi, Phan, Do Dang Khoa, Zhang, Jingwen, Ong, Pei-Shi, Thuya, Win Lwin, Soo, Ross, Wong, Andrea Li-Ann, Yong, Wei Peng, Lee, Soo Chin, Ho, Paul Chi-Lui, Sethi, Gautam, Goh, Boon Cher
Publicado no Oncotarget (2016)